Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat GABA ELISA Kit (AC3706)
Cat.#: ASET-2295
Specifications
Description Rat GABA ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of rat GABA concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1817 Human KCNN4 ELISA Kit (AC3228) Quantitative inquiry ASET-1514 Human Slit3 ELISA Kit (AC2925) Quantitative inquiry ASET-1202 Human ASTN2 ELISA Kit (AC2613) Quantitative inquiry ASET-1705 Rat Galanin ELISA Kit (AC3116) Quantitative inquiry ASET-2231 Human Dystrophin ELISA Kit (AC3642) Quantitative inquiry ASET-2146 Human PTF1A ELISA Kit (AC3557) Quantitative inquiry ASET-2120 Rat ARNT2 ELISA Kit (AC3531) Quantitative inquiry ASET-1548 Human FLJ39155 ELISA Kit (AC2959) Quantitative inquiry ASET-2431 Estradiol ELISA Kit (AC3842) Quantitative inquiry ASET-2393 Mouse Wnt5a ELISA Kit (AC3804) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket